Has Tsahi Samra, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,234 in general payments to Tsahi Samra, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tsahi Samra, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tsahi Samra, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tsahi Samra, MD

Hospitalist · Herrin, ILNPI 1255782082

Payments from drug & device makers

$1,234in general payments, 2019–2025

Across 32 payments — averaging $38.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$248
Genentech USA, Inc.$243
AbbVie$182
Abbott$176
Johnson & Johnson$170
E.r. Squibb & Sons, L.L.C.$151
plus $63 from 2 others

What the payments were for

Food & beverage$1,234100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	2	$248
Genentech USA, Inc.	2	$243
AbbVie	11	$182
Abbott	1	$176
Johnson & Johnson	9	$170
E.r. Squibb & Sons, L.L.C.	3	$151
AstraZeneca	2	$34
Merck	2	$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENSITE$176
VYNDAQEL$123
ELIQUIS$120
Esbriet$106

How this compares

$1,234 in reported general payments places this provider in the 90th percentile of 1,328 hospitalist providers in Illinois.

See all hospitalist providers in Illinois →

Medicare billing

Part B allowed, 2024

$111,098

Medicare patients

297

Services billed

991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	17	$9,754
Memantine Hcl	13	$700
Telmisartan	13	$262
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	21	$150
Metoprolol Succinate	11	$140
Pantoprazole Sodium	16	$138
Levofloxacin	18	$105
Carvedilol	16	$100
Methylprednisolone	11	$92
Prednisone	13	$83
Furosemide	22	$81
Amlodipine Besylate	20	$75
Doxycycline Hyclate	12	$59
Potassium Chloride	11	$49
Atorvastatin Calcium	14	$34

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$248	$9,75417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,328 hospitalist providers in Illinois.

Other hospitalist in Herrin

Saad AlviCarbondale$2.7M
Odulola OdusanyaLibertyville$544K
Ami ShahEvanston$475K
Salih SamoChicago$292K
Eric GluckChicago$80K
Jorge Gomez AlarconLake Forest$72K
Ann TranEvanston$61K
Jagadeeshu SiramDanville$50K
Alvin ThomasChicago$28K
Keith SummaChicago$24K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →